Practice
Open Access
Epinephrine in anaphylaxis
Florence Morriello and Martin Chapman
CMAJ May 15, 2023 195 (19) E683; DOI: https://doi.org/10.1503/cmaj.221319
Florence Morriello
Temerty Faculty of Medicine (Morriello, Chapman) and Divisions of General Internal Medicine (Morriello), Critical Care Medicine (Chapman) and Anesthesiology & Pain Medicine (Chapman), University of Toronto, Toronto, Ont.; Department of Medicine (Morriello), Division of General Internal Medicine (Morriello), Northern Ontario School of Medicine, Sudbury, Ont.
MD MScMartin Chapman
Temerty Faculty of Medicine (Morriello, Chapman) and Divisions of General Internal Medicine (Morriello), Critical Care Medicine (Chapman) and Anesthesiology & Pain Medicine (Chapman), University of Toronto, Toronto, Ont.; Department of Medicine (Morriello), Division of General Internal Medicine (Morriello), Northern Ontario School of Medicine, Sudbury, Ont.
BMIn this issue
Article extras
Article tools
Epinephrine in anaphylaxis
Florence Morriello, Martin Chapman
CMAJ May 2023, 195 (19) E683; DOI: 10.1503/cmaj.221319
Jump to section
- Article
- Rates of anaphylaxis are increasing
- Epinephrine should be given immediately on recognition of anaphylaxis
- Intramuscular epinephrine should be used for initial treatment
- Medication errors with epinephrine are common and can be dangerous
- Intravenous infusions of epinephrine should be used only for refractory anaphylaxis
- Footnotes
- References
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.